Similar Posts
Why is it the right time to buy Assertio Holdings Inc :(XNAS:ASRT)?
Assertio Holdings, Inc. (NASDAQ: ASRT) is a commercial pharmaceutical company specializing in treatments for neurology, rheumatology, pain and inflammation. Their diverse range of pharmaceutical offerings includes products like INDOCIN, addressing conditions from rheumatoid arthritis to acute painful shoulder and gouty arthritis.
The company aims to redefine the pharmaceutical landscape by developing and delivering high-quality, differentiated therapies that address unmet medical needs. With a focus on innovation, integrity, and patient-centered solutions, Assertio envisions a future where healthcare is transformed by its products and services.
Plug Power, Inc.: Building an Integrated Green Hydrogen Ecosystem
Plug Power is a hydrogen-focused energy company developing fuel cells, hydrogen production, storage, and distribution solutions, primarily targeting material handling, mobility, and stationary power markets
Burke & Herbert Financial Services Corp.
HRB Financials operates as the bank holding company, providing various community banking products and services in Virginia and Maryland.
Slide Insurance Holdings, Inc.
Ticker: SLDE (NASDAQ)
Headquarters: Tampa, FL, USA
Founded: 2021
CEO: Bruce Thomas Lucas (as of 2025)
Industry: Property-Casualty Insurers
Shall Investors punt on this pharmaceutical penny stock: Avenue Therapeutics Inc. (NASDAQ: ATXI)?
Avenue Therapeutics (XNAS: ATXI) is a specialty pharmaceutical company that develops and markets pharmaceutical products for the acute care setting. Its mission is to develop IV tramadol, a potential alternative that could reduce the use of conventional opioids, for patients suffering from acute pain in the U.S. Avenue is headquartered in New York City and was founded by Fortress Biotech, Inc. Fortress is focused on acquiring, developing and commercializing high-potential marketed and development-stage drugs and drug candidates.
How the diversified business model of Catalent, Inc (XNYS:CTLT) provides a safe investment opportunity?
Catalent, Inc. (NYSE: CTLT) is a leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, gene therapies, and consumer health products. Operating as a Contract Development and Manufacturing organization (CDMO), the company serves a wide range of customers in the pharmaceutical, biotech, and consumer health industries.
It operates under four main segments: biologics, softgel and oral technologies, oral and specialty delivery, and clinical supply services. The company is known for its expertise in developing and manufacturing complex and difficult-to-formulate products, and for its ability to rapidly scale up production to meet the needs of its customers.